Sign In

Login

Password

Forgot Password ? Sign Up

Lėtinė mieloleukemija (Lithuanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lėtinė mieloleukemija" in Lithuanian language version.

refsWebsite
Global rank Lithuanian rank
13nih.gov
4th place
12th place
1thelancet.com
2,393rd place
1,606th place
1ihot.lt
low place
low place
1web.archive.org
1st place
1st place
1clinicaltrials.gov
5,225th place
5,140th place

clinicaltrials.gov

ihot.lt

nih.gov

ncbi.nlm.nih.gov

  • Goldman et al. Chronic myeloid leukemia: a historical perspective. Semin Hematol. 2010 Oct;47(4):302-11. doi: 10.1053/j.seminhematol.2010.07.001. http://www.ncbi.nlm.nih.gov/pubmed/20875546
  • Faderl et al. Chronic myelogenous leukemia: biology and therapy. http://www.ncbi.nlm.nih.gov/pubmed/10428738
  • Savage et al. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol. 1997 Jan;96(1):111-6. http://www.ncbi.nlm.nih.gov/pubmed/9012696?dopt=Abstract
  • Vardiman et al. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002 Oct 1;100(7):2292-302. http://www.ncbi.nlm.nih.gov/pubmed/12239137
  • Tefferi et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007 Aug 15;110(4):1092-7. Epub 2007 May 8. http://www.ncbi.nlm.nih.gov/pubmed/17488875
  • Baccarani et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013 Aug 8;122(6):872-84. doi: 10.1182/blood-2013-05-501569. Epub 2013 Jun 26. http://www.ncbi.nlm.nih.gov/pubmed/23803709
  • O’Brien et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003 Mar 13;348(11):994-1004. http://www.ncbi.nlm.nih.gov/pubmed/12637609?dopt=Abstract
  • Baccarani et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009 Dec 10;27(35):6041-51. doi: 10.1200/JCO.2009.25.0779. Epub 2009 Nov 2. http://www.ncbi.nlm.nih.gov/pubmed/19884523?dopt=Abstract
  • Kantarijian et al. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. Blood. 2007 Nov 15;110(10):3540-6. Epub 2007 Aug 22. http://www.ncbi.nlm.nih.gov/pubmed/17715389?dopt=Abstract
  • Kantarjian et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2010 Jun 17;362(24):2260-70. doi: 10.1056/NEJMoa1002315. Epub 2010 Jun 5. http://www.ncbi.nlm.nih.gov/pubmed/20525995
  • Cortes et al. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial. J Clin Oncol. 2012 Oct 1;30(28):3486-92. Epub 2012 Sep 4. http://www.ncbi.nlm.nih.gov/pubmed/22949154
  • Cortes et al. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. http://www.ncbi.nlm.nih.gov/pubmed/24180494
  • Larson et al. Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up. Leukemia. 2012 Oct;26(10):2197-203. doi: 10.1038/leu.2012.134. Epub 2012 May 18. http://www.ncbi.nlm.nih.gov/pubmed/22699418

thelancet.com

web.archive.org